BCL2L1 and ovarian carcinoma: When all cases of ovarian carcinoma were stratified by Bcl-xL expression, we found that the prognosis of patients with low Beclin 1 expression was significantly poorer than that with high Beclin 1 expression in the Bcl-xL+ group (P<0.0001, Figure 3E).